#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chordoma Pelizaeus-Merzbacher disease Hereditary haemorrhagic telangiectasia Tourette's disorder Pituitary-dependent Cushing's syndrome Alveolar rhabdomyosarcoma Dedifferentiated liposarcoma Exudative retinopathy Arterial disorder Non-Hodgkin's lymphoma unspecified histology indolent Fibrodysplasia ossificans progressiva Mucopolysaccharidosis I Phenylketonuria Hereditary angioedema with C1 esterase inhibitor deficiency ROHHAD syndrome More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Treatment Lymphatic malformation – Trials in Disease Burkitt’s lymphoma – Diagnostics Hereditary neuropathic amyloidosis – Treatment X-linked lymphoproliferative syndrome – Trials in Disease Lymphangioma – Basic Information Netherton’s syndrome – Life with Disease Marginal zone lymphoma MELAS syndrome Hepatic angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Carbonate Abatacept Fenfluramine Hydrochloride Dobutamine Daunorubicin AZD5335 Fluocinolone Acetonide Sodium Iodide (131I) ALE1 Paclitaxel Obaluronate Anhydrous Caffeine Ambroxol Hydrochloride Tamsulosin Hydrochloride Fampridine Bendamustine Travoprost GS-1720 Tobramycin Mogamulizumab Azd5863 More therapies…

    Learn about Your Condition

    Clostridium difficile colitis Infant sedation Respiratory distress Acoustic neuroma Post procedural infection Metastases to peritoneum Psychogenic seizure Hypoaesthesia Skin bacterial infection Cystic fibrosis Hypoglycaemia Neurofibrosarcoma Narcolepsy Magnetic resonance imaging Pulmonary hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Frisius

Frisius

Henri Dunantweg 2, Heerenveen, 8934 AD, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Gemcitabine
    • Lenalidomide
    Belgium Bulgaria Croatia Czechia France Greece +5

  • Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tanimilast
    Austria Bulgaria Czechia Germany Greece Hungary +6

  • Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Roflumilast
    • Tanimilast
    Austria Bulgaria Croatia Czechia Estonia Germany +8

  • Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Lenalidomide
    The Netherlands Norway

  • Study Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Carfilzomib
    • Dexamethasone
    Belgium Czechia Germany Greece Italy The Netherlands +2

  • Study of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pembrolizumab
    The Netherlands

  • Study on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • PIK3CA-activated mutation
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Alpelisib
    The Netherlands

  • Study on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    • Pembrolizumab
    The Netherlands

  • Study of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bosutinib
    • Dasatinib
    • Imatinib Mesilate
    The Netherlands

  • Study of Nivolumab for Patients with Esophageal Cancer Undergoing Active Surveillance After Chemoradiation

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Nivolumab
    The Netherlands
Previous Page
1 … 6 7 8 9 10 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!